Skip to main content

Search

Reset all filters
62 Result(s)
Sort by

Skin Diseases

Skin Diseases

Skin Diseases | We discover and develop breakthrough therapies that can be used to prevent, treat and repair many inflammatory and fibrotic diseases.
Small Molecule Drug Discovery

Small Molecule Drug Discovery

Boehringer Ingelheim scientists continue to expand the horizons of what small molecule drugs can achieve.
Lung Diseases

Lung Diseases

Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer.
Partnering

Partnering

We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Research at the Regional Center Vienna

Research at the Regional Center Vienna

The Regional Center Vienna counts for 33 countries and has been a central pillar in Boehringer Ingelheim’s global research network.
Improving Access to Healthcare

Improving Access to Healthcare

According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care.
Code of Conduct

Code of Conduct

Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
Human Health Innovation

Human Health Innovation

Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need.
Innovation in Oncology and Cancer Immunology Research

Innovation in Oncology and Cancer Immunology Research

We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Cancer cell directed therapies

Cancer cell directed therapies

At Boehringer Ingelheim, we are investigating cancer cell directed therapies that target key cancer drivers and hallmarks to directly kill cancer cells.
Solidarity with Ukraine

Solidarity with Ukraine

Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations.
Computational Biology & Digital Sciences

Computational Biology & Digital Sciences

At Boehringer Ingelheim, we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies.